The Point-of-Care Molecular Diagnostics Market is experiencing robust expansion driven by rising demand for rapid, accurate, ...

DELRAY BEACH, Fla., Sept. 19, 2025 /PRNewswire/ -- The global In Vitro Diagnostics Quality Control Market, valued at US$1.58 billion in 2024, stood at US$1.65 billion in 2025 and is projected to ...

New techniques and materials are spurring the development of next-generation molecular diagnostics, critical for disease prevention and treatment. Here we present emerging technologies and tools in ...

To date, the limited efforts toward advancing cancer diagnostics in LMICs have focused on basic pathology services. Molecular diagnostics—now a standard part of cancer management in high-income ...

Clinical Utility of Pharmacogenomics and Genetic Testing Remains an Issue Through rapid advances in research and clinical applications, molecular diagnostics has grown from a genomic and proteomic ...

The current pandemic has impacted nearly every aspect of daily life. One strategy to help public health professionals understand and control the spread of SARS-CoV-2 is the widespread testing of ...

REDMOND, Wash.--(BUSINESS WIRE)--Anavasi Diagnostics, an NIH/RADx funded medical technology company developing novel molecular diagnostic testing for the point-of-care (POC) market, announced the Food ...

SALT LAKE CITY, Sept. 17, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of ...

A look at the shareholders of Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) can tell us which group is most powerful. With 50% stake, hedge funds possess the maximum shares in the company. That is, ...